Effect of renal function on argatroban therapy in heparin-induced thrombocytopenia

Journal of Thrombosis and Thrombolysis

Volumn 22, Issue 3, 2006, Pages 169-176

  Guzzi, Louis M ^a   McCollum, David A ^b   Hursting, Marcie J ^c  

^a FLORIDA HOSPITAL   (United States)

^b CTI Clinical Trial and Consulting Services   (United States)

^c Clinical Science Consulting   (United States)

Author keywords

Argatroban; Dosing; Heparin induced thrombocytopenia; Renal impairment

Indexed keywords

ALANINE AMINOTRANSFERASE; ARGATROBAN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CREATININE; HEPARIN;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMPUTATION; ANTICOAGULANT THERAPY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CREATININE CLEARANCE; DISEASE SEVERITY; DOSE KIDNEY FUNCTION RELATION; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG WITHDRAWAL; FATALITY; FEMALE; FOLLOW UP; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; REGRESSION ANALYSIS; SIDE EFFECT;

AGED; ANTICOAGULANTS; COHORT STUDIES; CREATININE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEPARIN; HUMANS; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; PARTIAL THROMBOPLASTIN TIME; PIPECOLIC ACIDS; PLATELET AGGREGATION INHIBITORS; RETROSPECTIVE STUDIES; THROMBOCYTOPENIA;

EID: 33845269804     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-006-9019-2     Document Type: Article

References (28)

1. Hirsh J, Heddle N, Kelton JG (2004) Treatment of heparin induced thrombocytopenia: A critical review. Arch Int Med 164:361-369
2. Warkentin TE, Greinacher A (2004) Heparin-induced thrombocytopenia: recognition, treatment, and prevention. Chest 126:311S-337S
3. Lewis BE, Wallis DE, Berkowitz SD et al (2001) Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia. Circulation 103:1838-1843
4. Lewis BE, Wallis DE, Leya F, Hursting MJ, Kelton JG (2003) Argatroban anticoagulation in patients with heparin-induced thrombocytopenia. Arch Intern Med 163:1849-1856
5. LaMonte MP, Brown PM, Hursting MJ (2004) Stroke in patients with heparin-induced thrombocytopenia and the effect of argatroban therapy. Crit Care Med 32:976-980
6. Lewis BE, Wallis DE, Hursting MJ, Levine RL, Leya F (2006) Effects of argatroban therapy, demographic variables, and platelet count on thrombotic risks in heparin-induced thrombocytopenia. Chest 129:1407-1416
7. Product Information. Argatroban. GlaxoSmithKline Research Triangle Park, NC April 2005
8. Fischer KG (2002) Hirudin in renal insufficiency. Semin Thromb Hemost 28:467-482
9. O'Shea SI, Ortel TL, Kovalik EC (2003) Alternative methods of anticoagulation for dialysis-dependent patients with heparin-induced thrombocytopenia. Semin Dial 16:61-67
10. Dager WE, White RH (2003) Argatroban for heparin-induced thrombocytopenia in hepato-renal failure and CVVHD. Ann Pharmacother 37:1232-1236
11. Reichert MG, MacGregor DA, Kincaid EH, Dolinski SY (2003) Excessive anticoagulation for heparin-induced thrombocytopenia. Ann Pharmacother 37:652-654
12. Williamson DR, Boulanger I, Tardif M, Albert M, Gregoire G (2004) Argatroban dosing in intensive care patients with acute renal failure and liver dysfunction. Pharmacotherapy 24:409-414
13. Murray PT, Reddy BV, Grossman EJ et al (2004) A prospective comparison of three argatroban treatment regimens during hemodialysis in end-stage renal disease. Kidney Int 66:2446-2453
14. Arpino PA, Hallisey RK (2004) Effect of renal function on the pharmacodynamics of argatroban. Ann Pharmacother 38:25-29
15. Izawa O, Katsuki M, Komatsu T, Iida S (1986) Pharmacokinetic studies of argatroban (MD-805) in human: Concentrations of argatroban and its metabolites in plasma, urine and feces during and after drip intravenous infusion. Jap Pharmacol Ther 14:251-263
16. Swan SK, Hursting MJ (2000) The pharmacokinetics and pharmacodynamics of argatroban: Effects of age, gender and hepatic or renal dysfunction. Pharmacotherapy 20:318-329
17. Matsuo T, Yamada T, Yamanashi R, Ryo R (1990) Anticoagulant therapy with MD805 of a hemodialysis patient with heparin-induced thrombocytopenia. Thromb Res 58:663-666
18. Tang IY, Cox DS, Patel K et al (2005) Argatroban and renal replacement therapy in patients with heparin-induced thrombocytopenia. Ann Pharmacother 39:231-236
19. Reddy BV, Grossman EJ, Nahlik L, Trevino S, Hursting MJ, Murray PT (2005) Argatroban anticoagulation in patients with heparin-induced thrombocytopenia requiring renal replacement therapy. Ann Pharmacol 39:1601-1605
20. Koide M, Yamamoto S, Matsuo M, Suzuki S, Arima N, Matsuo T (1995) Anticoagulation for heparin-induced thrombocytopenia with spontaneous platelet aggregation in a patient requiring hemodialysis. Nephrol Dial Transplant 10:2137-2140
21. Ota K, Akizawa T, Hirasawa Y, Agishi T, Matsui N (2003) Effects of argatroban as an anticoagulant for haemodialysis in patients with antithrombin III deficiency. Nephrol Dial Transplant 18:1623-1630
22. Cockcroft DW, Gault MH (1976) Prediction of creatine clearance from serum creatinine. Nephron 16:31-41
23. Baghdasarian S, Singh I, Militello M, Bartholomew J, Begelman S (2004) Argatroban dosage in critically ill patients with HIT [abstract]. Blood 104:493a
24. Levine RL, Hursting MJ, McCollum D (2006) Argatroban therapy in heparin-induced thrombocytopenia with hepatic dysfunction. Chest 129:1167-1175
25. Escolar G, Bozzo J, Maragall S (2005) Extensive prolongation of aPTT with argataroban in an elderly patient with improving renal function, normal hepatic enzymes, and metastatic lung cancer. Ann Pharmacother 39:1119-1123
26. Smythe M, Stephens JL, Koerber JM, Mattson JC (2005) A comparison of leplrudin and argatroban outcomes. Clin Appl Thrombosis/Hemostasis 11:371-374
27. Kiser TH, Jung R, MacLaren R, Fish DN (2005) Evaluation of diagnostic tests and argatroban or lepirudin therapy in patients with suspected heparin-induced thrombocytopenia. Pharmacotherapy 25:1736-1745
28. Kodityal S, Nguyen PH, Kodityal A, Sherer J, Hursting MJ, Rice L (2006) Argatroban for suspected heparin-induced thrombocytopenia: Contemporary experience at a large teaching hospital. J Intensive Care Med 21:86-92